Lv61
1970 积分 2021-07-29 加入
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
6小时前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
11天前
已完结
Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation
15天前
已完结
Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice
15天前
已完结
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
15天前
已完结
Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development
15天前
已完结
Liver cirrhosis: An overview of experimental models in rodents
24天前
已完结
A Human In Vitro T Cell Exhaustion Model for Assessing Immuno-Oncology Therapies
25天前
已完结
Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
26天前
已完结
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer
26天前
已完结
皖公网安备34019202002308
